Ann: Monepantel Principal Metabolite Shows Anti-Cancer Activity, page-22

I am getting used to this pattern with PAA, having followed it since 2013 and held some for 99% of the time: positive announcement, price spike for a short time before the price once again declines. At least this time it did not go below the price before the announcement (yet). I do not expect any substantial improvement in price until the trial is completed and if the results are consistent with the experimental hypothesis. But long suffering PAA holders do with some sustained positive results!